TERM ID="NYU_TERM_1" STRING="addition" FREQUENCY=1 START=1365 END=1373 LEMMA="ADDITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="administrations" FREQUENCY=1 START=1294 END=1309 LEMMA="ADMINISTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="bioavailability" FREQUENCY=1 START=966 END=981 LEMMA="BIOAVAILABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="bisphosphonates" FREQUENCY=1 START=1086 END=1101 LEMMA="BISPHOSPHONATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="chronic disease" FREQUENCY=1 START=86 END=101 LEMMA="CHRONIC DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="chronic disease of the osseous system" FREQUENCY=1 START=86 END=123 LEMMA="OSSEOUS SYSTEM CHRONIC DISEASE" LEMMA_FREQUENCY=1 HEAD_TERM="chronic disease" HEAD_LEMMA="CHRONIC DISEASE"
TERM ID="NYU_TERM_7" STRING="clinical studies" FREQUENCY=1 START=817 END=833 LEMMA="CLINICAL STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="complications" FREQUENCY=1 START=983 END=996 LEMMA="COMPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="fine example" FREQUENCY=1 START=1131 END=1143 LEMMA="FINE EXAMPLE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="gastrointestinal tract" FREQUENCY=1 START=1026 END=1048 LEMMA="GASTROINTESTINAL TRACT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="i.v" FREQUENCY=2 START=12 END=15 LEMMA="I.V" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_12" STRING="i.v" FREQUENCY=2 START=1813 END=1816 LEMMA="I.V" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="ibandronate" FREQUENCY=2 START=1197 END=1208 LEMMA="IBANDRONATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="ibandronate" FREQUENCY=2 START=1818 END=1829 LEMMA="IBANDRONATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="ibandronate administration" FREQUENCY=1 START=17 END=43 LEMMA="IBANDRONATE ADMINISTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="identified properties" FREQUENCY=1 START=728 END=749 LEMMA="IDENTIFIED PROPERTY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="increased fracture risk" FREQUENCY=1 START=199 END=222 LEMMA="INCREASED FRACTURE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="intravenous administration" FREQUENCY=1 START=1167 END=1193 LEMMA="INTRAVENOUS ADMINISTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="intravenous administration of ibandronate" FREQUENCY=1 START=1167 END=1208 LEMMA="IBANDRONATE INTRAVENOUS ADMINISTRATION" LEMMA_FREQUENCY=1 HEAD_TERM="intravenous administration" HEAD_LEMMA="INTRAVENOUS ADMINISTRATION"
TERM ID="NYU_TERM_20" STRING="line drugs" FREQUENCY=1 START=876 END=886 LEMMA="LINE DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="line drugs for osteoporosis" FREQUENCY=1 START=876 END=903 LEMMA="OSTEOPOROSI LINE DRUG" LEMMA_FREQUENCY=1 HEAD_TERM="line drugs" HEAD_LEMMA="LINE DRUG"
TERM ID="NYU_TERM_22" STRING="literature reports" FREQUENCY=1 START=1882 END=1900 LEMMA="LITERATURE REPORT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="low-energy fractures" FREQUENCY=1 START=463 END=483 LEMMA="LOW-ENERGY FRACTURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="medical agents" FREQUENCY=1 START=703 END=717 LEMMA="MEDICAL AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="oral preparations" FREQUENCY=1 START=921 END=938 LEMMA="ORAL PREPARATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="osseous system" FREQUENCY=1 START=109 END=123 LEMMA="OSSEOUS SYSTEM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="osteoporosis" FREQUENCY=4 START=254 END=266 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_28" STRING="osteoporosis" FREQUENCY=4 START=555 END=567 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_29" STRING="osteoporosis" FREQUENCY=4 START=891 END=903 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_30" STRING="osteoporosis" FREQUENCY=4 START=1716 END=1728 LEMMA="OSTEOPOROSI" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_31" STRING="osteoporosis therapy" FREQUENCY=2 START=420 END=440 LEMMA="OSTEOPOROSIS THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_32" STRING="osteoporosis therapy" FREQUENCY=2 START=1833 END=1853 LEMMA="OSTEOPOROSIS THERAPY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="osteoporosis therapy Osteoporosis" FREQUENCY=1 START=47 END=80 LEMMA="OSTEOPOROSIS THERAPY OSTEOPOROSI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="parenteral administration" FREQUENCY=1 START=1057 END=1082 LEMMA="PARENTERAL ADMINISTRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="parenteral administration of bisphosphonates" FREQUENCY=1 START=1057 END=1101 LEMMA="BISPHOSPHONATE PARENTERAL ADMINISTRATION" LEMMA_FREQUENCY=1 HEAD_TERM="parenteral administration" HEAD_LEMMA="PARENTERAL ADMINISTRATION"
TERM ID="NYU_TERM_36" STRING="primary goals" FREQUENCY=1 START=403 END=416 LEMMA="PRIMARY GOAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="primary goals of osteoporosis therapy" FREQUENCY=1 START=403 END=440 LEMMA="OSTEOPOROSIS THERAPY PRIMARY GOAL" LEMMA_FREQUENCY=1 HEAD_TERM="primary goals" HEAD_LEMMA="PRIMARY GOAL"
TERM ID="NYU_TERM_38" STRING="reduced fracture risks" FREQUENCY=1 START=1622 END=1644 LEMMA="REDUCED FRACTURE RISK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="regular contact" FREQUENCY=1 START=1465 END=1480 LEMMA="REGULAR CONTACT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="therapeutic centre" FREQUENCY=1 START=1502 END=1520 LEMMA="THERAPEUTIC CENTRE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="therapeutic efficacy" FREQUENCY=2 START=751 END=771 LEMMA="THERAPEUTIC EFFICACY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_42" STRING="therapeutic efficacy" FREQUENCY=2 START=1578 END=1598 LEMMA="THERAPEUTIC EFFICACY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_43" STRING="therapeutic options" FREQUENCY=1 START=652 END=671 LEMMA="THERAPEUTIC OPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="therapy mode" FREQUENCY=1 START=1348 END=1360 LEMMA="THERAPY MODE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="three-month intervals" FREQUENCY=1 START=1264 END=1285 LEMMA="THREE-MONTH INTERVAL" LEMMA_FREQUENCY=1
